Song WJ et al (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45(5):1479–1481

Article  PubMed  Google Scholar 

Song WJ et al (2016) Defining chronic cough: a systematic review of the epidemiological literature. Allergy Asthma Immunol Res 8(2):146–155

Article  PubMed  Google Scholar 

Meltzer EO et al (2021) Prevalence and burden of chronic cough in the united states. J Allergy Clin Immunol Pract 9(11):4037-4044.e2

Article  PubMed  Google Scholar 

French C et al (2017) Change in psychologic, physiologic, and situational factors in adults after treatment of chronic cough. Chest 152

French CL et al (1998) Impact of chronic cough on quality of life. Arch Intern Med 158(15):1657–1661

Article  CAS  PubMed  Google Scholar 

Brignall K, Jayaraman B, Birring SS (2008) Quality of life and psychosocial aspects of cough. Lung 186:S55-58

Article  PubMed  Google Scholar 

Chamberlain SA et al (2015) The impact of chronic cough: a cross-sectional European survey. Lung 193(3):401–408

Article  PubMed  Google Scholar 

Dicpinigaitis PV, Tso R, Banauch G (2006) Prevalence of depressive symptoms among patients with chronic cough. Chest 130(6):1839–1843

Article  PubMed  Google Scholar 

McGarvey LA et al (2006) Prevalence of psychomorbidity among patients with chronic cough. Cough 2(1):4–4

Article  PubMed  PubMed Central  Google Scholar 

Dicpinigaitis PV (2021) Prevalence of stress urinary incontinence in women presenting for evaluation of chronic cough. ERJ Open Res 7(1):12

Article  Google Scholar 

Slovarp L, Loomis BK, Glaspey A (2018) Assessing referral and practice patterns of patients with chronic cough referred for behavioral cough suppression therapy. Chron Respir Dis 15:296–305

Article  PubMed  PubMed Central  Google Scholar 

Wright M, Sundar K, Herrick J, Barkmeier-Kraemer J (2021) Long-term treatment outcomes after behavioral speech therapy for chronic refractory cough. Lung 199:517–525

Article  PubMed  Google Scholar 

Song W-J et al (2013) Cough in the elderly population: relationships with multiple comorbidity. PLoS ONE 8(10):e78081–e78081

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song W, Hui C, Hull J, Birring S, McArvey L, Mazzone S, Chung K (2021) Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. The Lancet 9(5):533–544

CAS  PubMed  Google Scholar 

Chamberlain S, Garrod R, Birring SS (2013) Cough suppression therapy: does it work? Pulm Pharmacol Ther 26(5):524–527

Article  CAS  PubMed  Google Scholar 

Slovarp L et al (2021) Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy. Lung 199(3):263–271

Article  PubMed  PubMed Central  Google Scholar 

Chung KF, McGarvey L, Mazzone S (2016) Chronic cough and cough hypersensitivity syndrome. Lancet Respir Med 4(12):934–935

Article  PubMed  Google Scholar 

Morice AH et al (2011) Cough hypersensitivity syndrome: a distinct clinical entity. Lung 189(1):73–79

Article  CAS  PubMed  Google Scholar 

Morice AH (2010) The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung 188(Suppl 1):S87-90

Article  CAS  PubMed  Google Scholar 

Altman KW et al (2015) Neurogenic cough. Laryngoscope 125(7):1675–1681

Article  PubMed  Google Scholar 

Mazzone SB, McGarvey L (2021) Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough. Clin Pharmacol Ther 109(3):619–636

Article  PubMed  Google Scholar 

Grabczak EM et al (2020) Looking ahead to novel therapies for chronic cough. Part 1—peripheral sensory nerve targeted treatments. Exp Rev Respir Med 14(12):1217–1233

Article  CAS  Google Scholar 

Mitchell JE et al (2005) Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 31(3):295–306

Article  CAS  PubMed  Google Scholar 

Long L et al (2019) Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough. Respir Res 20(1):112

Article  PubMed  PubMed Central  Google Scholar 

Groneberg DA et al (2004) Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 170(12):1276–1280

Article  PubMed  Google Scholar 

Zhang M et al (2020) The role of ATP in cough hypersensitivity syndrome: new targets for treatment. J Thorac Dis 12(5):2781–2790

Article  PubMed  PubMed Central  Google Scholar 

Jia Y, Lee LY (2007) Role of TRPV receptors in respiratory diseases. Biochem Biophys Acta 1772(8):915–927

CAS  PubMed  Google Scholar 

Bonvini SJ et al (2015) Targeting TRP channels for chronic cough: from bench to bedside. Naunyn Schmiedebergs Arch Pharmacol 388(4):401–420

Article  CAS  PubMed  Google Scholar 

McLeod RL et al (2008) TRPV1 antagonists as potential antitussive agents. Lung 186(Suppl 1):S59-65

Article  CAS  PubMed  Google Scholar 

Belvisi MG et al (2017) XEN-D0501, a novel TRPV1 antagonist, does not reduce cough in refractory cough patients

Khalid S et al (2014) Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. J Allergy Clin Immunol 134(1):56-62.e4

Article  CAS  PubMed  Google Scholar 

Dicpinigaitis PV, McGarvey LP, Canning BJ (2020) P2X3-receptor antagonists as potential antitussives: summary of current clinical trials in chronic cough. Lung 198(4):609–616

Article  CAS  PubMed  Google Scholar 

Morice A et al (2021) Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study. Eur Respir J 58:1–12

Article  Google Scholar 

Friedrich C et al (2023) The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial. Respir Res 24(1):109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith JA et al (2020) Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med 8(8):775–785

Article  CAS  PubMed  Google Scholar 

Markham A (2022) Gefapixant: first approval. Drugs 82(6):691–695

Article  PubMed  Google Scholar 

Ando A et al (2016) Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control. Thorax 71(4):323–329

Article